Curevac gets 252 mln euro German grant for Covid-19 vaccine

The Tuebingen-based company, which floated on Nasdaq last month, said that in addition to funding development work on its vaccine candidate, it would use the grant "for the rapid expansion of the vaccine production"

Reuters

04 September, 2020, 07:15 pm

Last modified: 04 September, 2020, 07:14 pm

Representational Image. Photo: Reuters

Biotechnology startup up Curevac said on Friday it had received a 252 million euro ($298 million) research grant from the German government to support the development of the Covid-19 vaccine it is working on.

The Tuebingen-based company, which floated on Nasdaq last month, said that in addition to funding development work on its vaccine candidate, it would use the grant "for the rapid expansion of the vaccine production".

($1 = 0.8470 euros)

Keep updated, follow The Business Standard's Google news channel

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.